Interestingly, we find the genes involved in the NF-κB signaling pathway in response to TNF as the most enriched set of genes, thus confirming what we previously showed in the PRMT2low patients with AML (Fig. 3c, d). This evidence concerns the gene TNF and acute myeloid leukemia.